Recent

% | $
Quotes you view appear here for quick access.

Tesaro, Inc. (TSRO) Message Board

  • axconnith axconnith Mar 14, 2014 6:02 AM Flag

    Up almost 30% is way overdone.

    While the partnership makes sense, I agree with Sean Williams that the pps increase was overdone.

    "I am, however, a bit concerned by the enormity of today's run-up considering how little is known about AnaptysBio's cancer immunotherapy pipeline. Its anti-PD-1 antibody, for example, is only in preclinical studies, and a lot can change when going from preclinical to human trials. I'm ultimately hoping for success with this partnership for Tesaro, but I feel at this level its valuation simply doesn't make much sense."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • With the substantial price target upgrades just before the close yesterday and this morning you would be wise to cover whilst TSRO is still under $40, friend. The news was tremendously huge, and the upward price action on one of the worst days in the market in months proves it. Don't be stupid. COVER

      Sentiment: Strong Buy

 
TSRO
55.16-0.240(-0.43%)Mar 26 4:00 PMEDT